Annual information update

Hikma Pharmaceuticals Plc 14 May 2007 Annual Information Update LONDON, 14 May 2007. In accordance with Prospectus Rule 5.2, Hikma Pharmaceuticals PLC ('Hikma' or 'the Company')(LSE: HIK) (DIFX: HIK) sets out below a summary of the information which has been published or made available to the public over the previous 12 months. The information referred to in this Update was up to date at the time the information was published, but some information may now be out of date. Stock Exchange announcements Announcements made by the Company via RNS, a Regulatory Information Service, may be viewed and downloaded from the London Stock Exchange website ( www.londonstockexchange.com/marketnews) or from the press releases page on the Company's website at (http://investors.hikma.com/hikma/regulatorynews.jsp). The London Stock Exchange announcements made during the defined period are: Date of announcement Headline of announcement 23 Apr 07 Hikma appoints new CEO 20 Apr 07 Hikma acquires Thymoorgan 05 Apr 07 Block Listing 6-month review 05 Apr 07 Notification of transaction 03 Apr 07 LTIP awards 03 Apr 07 Notification of transaction 03 Apr 07 Notification of transaction 03 Apr 07 Notification of transaction 03 Apr 07 Notification of transaction 03 Apr 07 Notification of transaction 02 Apr 07 Notification of transaction 02 Apr 07 Notification of transaction 02 Apr 07 Notification of transaction 02 Apr 07 Voting rights and capital 23 Mar 07 Interest in shares 22 Mar 07 Final Results - Part 3 22 Mar 07 Final Results - Part 2 22 Mar 07 Final Results - Part 1 26 Jan 07 Completion of Acquisition 22 Jan 07 Hikma enters oncology market 18 Jan 07 Pre-close Trading Statement 21 Dec 06 Voting rights and capital 12 Dec 06 New board appointment 06 Dec 06 Director's Commitments 27 Nov 06 Notification of Transaction 22 Nov 06 Renewal of Contract 20 Nov 06 Notification of Site Visit 08 Nov 06 Notification of transaction 03 Nov 06 Section 198 Notification 27 Oct 06 Section 198 Notification 24 Oct 06 Trading update 09 Oct 06 Block Listing 6-month review 03 Oct 06 Notification of transaction 13 Sep 06 Interim Results 2006 - Part 1 13 Sep 06 Interim Results 2006 - Part 3 13 Sep 06 Interim Results 2006 - Part 2 11 Sep 06 Completion of Acquisition 13 Jul 06 Section 198 Notification 13 Jul 06 Pre-close Statement 21 Jun 06 Director Transaction 12 Jun 06 Section 198 Notification 31 May 06 Director Transaction 25 May 06 Results of AGM 25 May 06 AGM Trading Statement 24 May 06 Section 198 Notification 10 May 06 Hikma releases info on DIFX 27 Apr 06 Director/PDMR Shareholding All of the above announcements were also made by the Company via the Dubai International Financial Exchange ('DIFX') CANDI system. These announcements may be viewed and downloaded from the DIFX website (www.difx.ae). Additional DIFX announcements made during the defined period are: 26 Apr 2007 Notice of Annual Report and Accounts Documents filed with the Financial Services Authority The company has filed the following documents with the Financial Services Authority ('FSA') over the previous 12 months. These documents are or will be available to be viewed via the FSA's Document Viewing Facility or at the Company's registered office. Date filed with the FSA Document filed with the FSA 26 Apr 2007 2006 Annual Report and Accounts 26 Apr 2007 Notice of Annual General Meeting Documents filed with Companies House The Company has made the following filings with Companies House. Copies of these documents may be obtained from Companies House, Crown Way, Maindy, Cardiff CF14 3UZ or, if you are a registered user, they may be viewed and downloaded using Companies House Direct at www.direct.companieshouse.gov.uk. The Companies House filings made during the defined period are: Date filed with Companies Document filed with Companies House House 3 May 2007 2006 Annual Report and Accounts 18 Apr 2007 Form 88(2) - Return of Allotment of Shares 18 Apr 2007 Form 88(2) - Return of Allotment of Shares 18 Apr 2007 Form 88(2) - Return of Allotment of Shares 11 Apr 2007 Form 88(2) - Return of Allotment of Shares 7 Feb 2007 Form 88(2) - Return of Allotment of Shares 7 Feb 2007 Form 88(2) - Return of Allotment of Shares 4 Jan 2007 Form 288a - Appointment of Director 12 Oct 2006 Form 88(2) - Return of Allotment of Shares 27 Sep 2006 Form 363s - Annual Return 13 Sep 2006 Interim Unaudited Accounts 12 July 2006 Form 88(2) - Return of Allotment of Shares 12 July 2006 Form 88(2) - Return of Allotment of Shares 25 May 2006 Form 287 - Change of registered office 25 May 2006 Ordinary and special resolutions passed at AGM 23 May 2006 2005 Annual Report and Accounts 17 May 2006 Form 88(2) - Return of Allotment of Shares 17 May 2006 Form 88(2) - Return of Allotment of Shares Henry Knowles Company Secretary 14 May 2007 - ENDS - Enquiries: Hikma Pharmaceuticals plc +44 20 7399 2760 Henry Knowles, Company Secretary Susan Ringdal, Investor Relations Director Brunswick Group LLP +44 20 7404 5959 Jon Coles / Justine McIlroy / Alex Tweed Notes to Editors About Hikma Hikma Pharmaceuticals PLC is a multinational pharmaceutical group focused on developing, manufacturing and marketing a broad range of both branded and non-branded generic and in-licensed pharmaceutical products. Hikma's operations are conducted through three businesses: Generic, Branded and Injectable Pharmaceuticals. Hikma's operations are based principally in the Middle East and North Africa ('MENA') region, the United States and Europe. In 2006, the Group had revenue of $317 million and profit attributable to shareholders of $55 million. At 31 December 2006, the Group had over 2,443 employees. For news and other information, please visit www.hikma.com. This information is provided by RNS The company news service from the London Stock Exchange

Companies

Hikma Pharmaceuticals (HIK)
UK 100
FTSE quotes by TradingView

Latest directors dealings

All directors dealings today